CD38 Immunophenotyping by Flow Cytometry Test
Comprehensive Introduction to CD38 Immunophenotyping
CD38 Immunophenotyping by Flow Cytometry represents a cutting-edge diagnostic approach in modern hematology and oncology. This sophisticated test plays a pivotal role in identifying and characterizing abnormal cell populations, particularly in blood cancers and immune disorders. The CD38 protein, a transmembrane glycoprotein expressed on various immune cells, serves as a crucial marker for disease detection and monitoring.
Flow cytometry technology enables precise analysis of individual cells by measuring their physical and chemical characteristics as they pass through a laser beam. When combined with CD38-specific antibodies, this method provides invaluable insights into disease pathology, treatment response, and disease progression. The test’s importance extends beyond initial diagnosis to ongoing patient management and therapeutic decision-making.
What the CD38 Test Measures and Detects
The CD38 Immunophenotyping test specifically measures the presence and density of CD38 antigens on cell surfaces. This comprehensive analysis detects:
- CD38 protein expression levels on plasma cells and lymphocytes
- Abnormal cell populations in blood and bone marrow samples
- Presence of malignant plasma cells characteristic of multiple myeloma
- Immune cell subsets and their activation status
- Minimal residual disease following treatment
- Cell surface marker patterns indicative of hematological malignancies
Clinical Applications and Detection Capabilities
This advanced diagnostic tool excels in identifying specific disease markers that traditional methods might miss. The test’s sensitivity allows for early detection of abnormal cell populations, providing clinicians with critical information for timely intervention and treatment planning.
Who Should Consider CD38 Immunophenotyping Testing
This specialized test is recommended for individuals experiencing symptoms or conditions including:
- Unexplained bone pain or fractures
- Persistent fatigue and weakness
- Recurrent infections or compromised immunity
- Abnormal blood counts or unexplained anemia
- Patients with suspected multiple myeloma or plasma cell disorders
- Individuals undergoing evaluation for leukemia or lymphoma
- Patients requiring monitoring of existing hematological conditions
- Those with abnormal protein levels in blood or urine tests
High-Risk Patient Groups
Patients with family history of hematological cancers, individuals with monoclonal gammopathy of undetermined significance (MGUS), and those with previous abnormal bone marrow findings should strongly consider this comprehensive evaluation.
Significant Benefits of CD38 Testing
Choosing CD38 Immunophenotyping by Flow Cytometry offers numerous advantages for patients and healthcare providers:
- Early Disease Detection: Identifies abnormal cell populations before symptoms become severe
- Precise Diagnosis: Provides definitive characterization of hematological malignancies
- Treatment Guidance: Helps determine appropriate therapeutic approaches
- Monitoring Capability: Tracks disease progression and treatment response
- Minimal Residual Disease Detection: Identifies low levels of disease after treatment
- Rapid Results: Same-day reporting for timely clinical decisions
- Cost-Effective: Affordable testing with significant diagnostic value
Understanding Your Test Results
Interpreting CD38 Immunophenotyping results requires professional medical expertise, but general guidance includes:
Normal Results Interpretation
Normal CD38 expression patterns vary by cell type and patient age. Your healthcare provider will compare your results against established reference ranges and consider your clinical presentation.
Abnormal Findings and Clinical Significance
Elevated CD38 expression on plasma cells often indicates multiple myeloma or related plasma cell disorders. Abnormal patterns may suggest:
- Active multiple myeloma requiring immediate intervention
- Other plasma cell dyscrasias needing further evaluation
- Immune system activation or autoimmune conditions
- Response to specific therapies targeting CD38
Follow-up Recommendations
Based on your results, your healthcare provider may recommend additional testing, treatment initiation, or regular monitoring. Always discuss your specific results and their implications with your oncologist or hematologist.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $88 |
| Regular Price | $112 |
Service Details
Turnaround Time: Sample collection daily by 9 AM with same-day reporting
Sample Requirements: 3 mL whole blood in EDTA tube AND 3 mL whole blood in Sodium Heparin tube, or 2 mL bone marrow in Sodium Heparin tube
Shipping Instructions: Immediate shipment at 18-22°C – DO NOT REFRIGERATE OR FREEZE
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas. Our network includes specialized collection centers in:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and Midwest regions
- Houston and Texas metropolitan areas
- Miami and Florida locations
- Philadelphia and Northeast centers
- San Francisco Bay Area facilities
- Washington D.C. and Baltimore regions
Take Action for Your Health Today
Don’t wait to get the answers you need for proper diagnosis and treatment. Our CD38 Immunophenotyping by Flow Cytometry test provides critical information that can significantly impact your healthcare journey. With same-day results and affordable pricing, there’s no reason to delay this essential diagnostic evaluation.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your test or speak with our medical specialists. Our team is ready to assist you with scheduling, answer your questions, and ensure you receive the highest quality diagnostic care.
Remember to provide your complete clinical history when scheduling your test to ensure optimal sample processing and accurate result interpretation. Our experienced staff will guide you through the entire process, from sample collection to result delivery.
